No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose. / Vilsbøll, Tina; Krarup, T; Madsbad, S; Holst, Jens Juul.
In: Diabetic Medicine, Vol. 18, No. 2, 01.02.2001, p. 144-149.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose
AU - Vilsbøll, Tina
AU - Krarup, T
AU - Madsbad, S
AU - Holst, Jens Juul
PY - 2001/2/1
Y1 - 2001/2/1
N2 - It has previously been shown that intravenous and subcutaneous administration of glucagon-like peptide (GLP)-1 concomitant with intravenous glucose results in reactive hypoglycaemia in healthy subjects. Since GLP-1 is also effective in Type 2 diabetic patients and is presently being evaluated as a therapeutic agent in this disease, it is important to investigate whether GLP-1 can cause hypoglycaemia in such patients.
AB - It has previously been shown that intravenous and subcutaneous administration of glucagon-like peptide (GLP)-1 concomitant with intravenous glucose results in reactive hypoglycaemia in healthy subjects. Since GLP-1 is also effective in Type 2 diabetic patients and is presently being evaluated as a therapeutic agent in this disease, it is important to investigate whether GLP-1 can cause hypoglycaemia in such patients.
M3 - Journal article
VL - 18
SP - 144
EP - 149
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - 2
ER -
ID: 170290